Research ExplorerPublications2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG...

2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.

Standard

2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial. / Bachner, M; Loriot, Y; Gross-Goupil, M; Zucali, P A; Horwich, A; Germa-Lluch, J-R; Kollmannsberger, C; Stoiber, F; Fléchon, A; Oechsle, Karin; Gillessen, S; Oldenburg, J; Cohn-Cedermark, G; Daugaard, G; Morelli, F; Sella, A; Harland, S; Kerst, M; Gampe, J; Dittrich, C; Fizazi, K; De Santis, M.

In: ANN ONCOL, Vol. 23, No. 1, 1, 01.2012, p. 59-64.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Bachner, M, Loriot, Y, Gross-Goupil, M, Zucali, PA, Horwich, A, Germa-Lluch, J-R, Kollmannsberger, C, Stoiber, F, Fléchon, A, Oechsle, K, Gillessen, S, Oldenburg, J, Cohn-Cedermark, G, Daugaard, G, Morelli, F, Sella, A, Harland, S, Kerst, M, Gampe, J, Dittrich, C, Fizazi, K & De Santis, M 2012, '2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.', ANN ONCOL, vol. 23, no. 1, 1, pp. 59-64. https://doi.org/10.1093/annonc/mdr052

APA

Bachner, M., Loriot, Y., Gross-Goupil, M., Zucali, P. A., Horwich, A., Germa-Lluch, J-R., Kollmannsberger, C., Stoiber, F., Fléchon, A., Oechsle, K., Gillessen, S., Oldenburg, J., Cohn-Cedermark, G., Daugaard, G., Morelli, F., Sella, A., Harland, S., Kerst, M., Gampe, J., ... De Santis, M. (2012). 2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial. ANN ONCOL, 23(1), 59-64. [1]. https://doi.org/10.1093/annonc/mdr052

Vancouver

Bachner M, Loriot Y, Gross-Goupil M, Zucali PA, Horwich A, Germa-Lluch J-R et al. 2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial. ANN ONCOL. 2012 Jan;23(1):59-64. 1. https://doi.org/10.1093/annonc/mdr052

Bibtex

@article{dd9a751b3d4947ca80c63ab37b98d1c4,
title = "2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.",
abstract = "2-¹?fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) has been recommended in international guidelines in the evaluation of postchemotherapy seminoma residuals. Our trial was designed to validate these recommendations in a larger group of patients.",
keywords = "Humans, Male, Sensitivity and Specificity, Retrospective Studies, *Positron-Emission Tomography, Glucose-6-Phosphate/*analogs & derivatives/diagnostic use, Radiopharmaceuticals/*diagnostic use, Seminoma/*radionuclide imaging, Testicular Neoplasms/*radionuclide imaging, Humans, Male, Sensitivity and Specificity, Retrospective Studies, *Positron-Emission Tomography, Glucose-6-Phosphate/*analogs & derivatives/diagnostic use, Radiopharmaceuticals/*diagnostic use, Seminoma/*radionuclide imaging, Testicular Neoplasms/*radionuclide imaging",
author = "M Bachner and Y Loriot and M Gross-Goupil and Zucali, {P A} and A Horwich and J-R Germa-Lluch and C Kollmannsberger and F Stoiber and A Fl{\'e}chon and Karin Oechsle and S Gillessen and J Oldenburg and G Cohn-Cedermark and G Daugaard and F Morelli and A Sella and S Harland and M Kerst and J Gampe and C Dittrich and K Fizazi and {De Santis}, M",
year = "2012",
month = jan,
doi = "10.1093/annonc/mdr052",
language = "English",
volume = "23",
pages = "59--64",
journal = "ANN ONCOL",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "1",

}

RIS

TY - JOUR

T1 - 2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.

AU - Bachner, M

AU - Loriot, Y

AU - Gross-Goupil, M

AU - Zucali, P A

AU - Horwich, A

AU - Germa-Lluch, J-R

AU - Kollmannsberger, C

AU - Stoiber, F

AU - Fléchon, A

AU - Oechsle, Karin

AU - Gillessen, S

AU - Oldenburg, J

AU - Cohn-Cedermark, G

AU - Daugaard, G

AU - Morelli, F

AU - Sella, A

AU - Harland, S

AU - Kerst, M

AU - Gampe, J

AU - Dittrich, C

AU - Fizazi, K

AU - De Santis, M

PY - 2012/1

Y1 - 2012/1

N2 - 2-¹?fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) has been recommended in international guidelines in the evaluation of postchemotherapy seminoma residuals. Our trial was designed to validate these recommendations in a larger group of patients.

AB - 2-¹?fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) has been recommended in international guidelines in the evaluation of postchemotherapy seminoma residuals. Our trial was designed to validate these recommendations in a larger group of patients.

KW - Humans

KW - Male

KW - Sensitivity and Specificity

KW - Retrospective Studies

KW - Positron-Emission Tomography

KW - Glucose-6-Phosphate/analogs & derivatives/diagnostic use

KW - Radiopharmaceuticals/diagnostic use

KW - Seminoma/radionuclide imaging

KW - Testicular Neoplasms/radionuclide imaging

KW - Humans

KW - Male

KW - Sensitivity and Specificity

KW - Retrospective Studies

KW - Positron-Emission Tomography

KW - Glucose-6-Phosphate/analogs & derivatives/diagnostic use

KW - Radiopharmaceuticals/diagnostic use

KW - Seminoma/radionuclide imaging

KW - Testicular Neoplasms/radionuclide imaging

U2 - 10.1093/annonc/mdr052

DO - 10.1093/annonc/mdr052

M3 - SCORING: Journal article

C2 - 21460378

VL - 23

SP - 59

EP - 64

JO - ANN ONCOL

JF - ANN ONCOL

SN - 0923-7534

IS - 1

M1 - 1

ER -